
KERNX Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: one flat price at every dose with consults, check-ins and labs included
KERNX Health stands out for its medical oversight and the pharmacy behind it.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Included
No insurance needed · Vetted by our editors
KERNX Health is a telehealth platform from KERNX Health LLC in Woodbridge, Virginia, selling compounded semaglutide injections, oral semaglutide tablets and tirzepatide at one price at every dose: $209, $279 and $299 a month, where each month is a 4-week supply. Provider consultations, shipping, monthly check-ins, health coaching and month-2 labs are included with no membership fee, and no treatment payment is collected unless a provider approves treatment.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to KERNX Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology

from $209/4 wks (billed per 4 weeks) · no insurance needed
KERNX Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $209/4 wks (billed per 4 weeks)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Labs · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored KERNX Health
Each dimension is scored algorithmically from KERNX Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $209/mo (per 4 weeks), KERNX Health runs about 17% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.5/10KERNX Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.1/10Online intake and platform experience (app/portal-based, consult included in the price); 6 platform features disclosed.
Trust & Safety15%
8.1/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
7.6/10KERNX Health treats patients in all 50 states.
Support10%
6.5/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this KERNX Health review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $209–$299/mo across 3 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with KERNX Health
We walked KERNX Health’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1The Start page opens a 4-step pre-assessment: which treatment you are exploring (shot, pill, compare both, or let a provider guide you)
- 2Step 2 asks whether you have read the FAQs
- 3Step 3 asks how you discovered KERNX Health
- 4Step 4 asks for your email address (first name optional) to continue to the secure assessment
- Every plan price, including prepaid and microdosing plans, is published on the pricing page before any intake.
- The pre-assessment asks only non-medical questions before it asks for an email address.
- Product Get Started buttons skip the pre-assessment and open the clinical intake directly at a height and weight question, labeled Powered by OpenLoop Health.
- The pricing page states there is no separate consultation fee and that the plan charge is processed only after a provider approves treatment.
- The dispensing pharmacy is described only as a licensed 503A compounding pharmacy partner identified in your treatment information.
- The site says the care team is available 7 days a week and answers messages within one business day.
KERNX Health customer support
GLP-1 medications KERNX Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$209/mo at every dose. Longer plans paid upfront: 3-mo $597 (12 wks), 6-mo $1,074 (24 wks), 12-mo $1,807 (52 wks). Microdosing plan $179/mo.
$279/mo at every dose. Longer plans paid upfront: 3-mo $777 (12 wks), 6-mo $1,434 (24 wks), 12-mo $2,717 (52 wks).
$299/mo at every dose. Longer plans paid upfront: 3-mo $717 (12 wks), 6-mo $1,374 (24 wks), 12-mo $2,717 (52 wks). Microdosing plan $199/mo.
Ready to get started?
Plans and promotions change often, so check KERNX Health's current pricing and active discounts before you decide.
What we like
- Publishes full pricing for every plan length before any intake or account creation
- One price at every dose, with no membership fee and no separate consultation fee
- Monthly provider check-ins, health coaching and month-2 lab testing are included in the plan price
- States plainly that no treatment payment is collected unless a provider approves treatment
- LegitScript seal is the genuine issued seal, not just a self-hosted badge
- Offers oral semaglutide tablets and lower-dose microdosing plans alongside injections
Watch-outs
- Each 'month' is a 4-week supply, so a full year of treatment is 13 supplies, not 12
- The lowest advertised rates ($139 and $209 per 4 weeks) require paying for 12 months upfront
- The dispensing pharmacy is not named on the site; it is identified only in your treatment information
- Refund requests are reviewed case by case rather than under a stated policy, so outcomes are discretionary
Is KERNX Health worth it?
KERNX Health built its program around one core idea: one flat price at every dose with consults, check-ins and labs included. It runs $209/month (per 4 weeks) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option, which very few providers offer.
KERNX Health is LegitScript-certified. It also doesn't charge you until you're approved and charges the same price at every dose.
How much KERNX Health costs
Compounded semaglutide runs $209–$279/month depending on plan, the low end a per 4 weeks and compounded tirzepatide runs $299/month (per 4 weeks).
Because KERNX Health's headline figure is a per 4 weeks, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare KERNX Health with the month-to-month prices of the alternatives below instead.
For a direct comparison, Belle Health runs semaglutide and tirzepatide from $199/month, so compare it with KERNX Health before you commit.
Medications: what KERNX Health prescribes
KERNX Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
KERNX Health's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who KERNX Health is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
KERNX Health treats patients in all 50 states, and dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
KERNX Health is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
KERNX Health stands out for its medical oversight and the pharmacy behind it.
Ready to start with KERNX Health?
From $209/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
KERNX Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare KERNX Health vs…
KERNX Health scores7.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
KERNX Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

KERNX Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this KERNX Health review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See KERNX Health's current pricing
Plans from $209/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.